Type 1 Diabetes (T1D) Market Report

Global and Region Type 1 Diabetes (T1D) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：171
  • REPORT CODE：GMM888917
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Type 1 Diabetes (T1D) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Type 1 Diabetes (T1D)market, defines the market attractiveness level of Type 1 Diabetes (T1D) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Type 1 Diabetes (T1D) industry, describes the types of Type 1 Diabetes (T1D) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Type 1 Diabetes (T1D) market and the development prospects and opportunities of Type 1 Diabetes (T1D) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Type 1 Diabetes (T1D) market in Chapter 13.

    By Player:

    • Biocon

    • Eli Lilly

    • Lexicon

    • Astellas

    • Boehringer Ingelheim

    • Sanofi

    • Samsung Bioepis

    • Janssen

    • Bristol-Myers Squibb

    • Novo Nordisk

    • Merck

    By Type:

    • Rapid Acting Insulin Analogs

    • Long Acting Insulin Analogs

    • Premix Insulin Analogs

    By End-User:

    • Children

    • Adults

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Type 1 Diabetes (T1D) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Type 1 Diabetes (T1D) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Type 1 Diabetes (T1D) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Type 1 Diabetes (T1D) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Type 1 Diabetes (T1D) Market Analysis and Outlook to 2022

    • 7.1 Global Type 1 Diabetes (T1D) Consumption (2017-2022)

    • 7.2 United States Type 1 Diabetes (T1D) Consumption (2017-2022)

    • 7.3 Europe Type 1 Diabetes (T1D) Consumption (2017-2022)

    • 7.4 China Type 1 Diabetes (T1D) Consumption (2017-2022)

    • 7.5 Japan Type 1 Diabetes (T1D) Consumption (2017-2022)

    • 7.6 India Type 1 Diabetes (T1D) Consumption (2017-2022)

    • 7.7 South Korea Type 1 Diabetes (T1D) Consumption (2017-2022)

    8 Region and Country-wise Type 1 Diabetes (T1D) Market Analysis and Outlook to 2028

    • 8.1 Global Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    • 8.2 United States Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    • 8.3 Europe Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    • 8.4 China Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    • 8.5 Japan Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    • 8.6 India Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    • 8.7 South Korea Type 1 Diabetes (T1D) Consumption Forecast (2022-2028)

    9 Global Type 1 Diabetes (T1D) Market Outlook by Types and Applications to 2022

    • 9.1 Global Type 1 Diabetes (T1D) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rapid Acting Insulin Analogs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Long Acting Insulin Analogs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Premix Insulin Analogs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Type 1 Diabetes (T1D) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adults Consumption and Growth Rate (2017-2022)

    10 Global Type 1 Diabetes (T1D) Market Outlook by Types and Applications to 2028

    • 10.1 Global Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Rapid Acting Insulin Analogs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Long Acting Insulin Analogs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Premix Insulin Analogs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)

    11 Global Type 1 Diabetes (T1D) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Type 1 Diabetes (T1D) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Type 1 Diabetes (T1D) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Type 1 Diabetes (T1D) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Type 1 Diabetes (T1D) Market Competitive Analysis

    • 14.1 Biocon

      • 14.1.1 Biocon Company Details

      • 14.1.2 Biocon Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biocon Type 1 Diabetes (T1D) Product and Service

    • 14.2 Eli Lilly

      • 14.2.1 Eli Lilly Company Details

      • 14.2.2 Eli Lilly Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eli Lilly Type 1 Diabetes (T1D) Product and Service

    • 14.3 Lexicon

      • 14.3.1 Lexicon Company Details

      • 14.3.2 Lexicon Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Lexicon Type 1 Diabetes (T1D) Product and Service

    • 14.4 Astellas

      • 14.4.1 Astellas Company Details

      • 14.4.2 Astellas Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Astellas Type 1 Diabetes (T1D) Product and Service

    • 14.5 Boehringer Ingelheim

      • 14.5.1 Boehringer Ingelheim Company Details

      • 14.5.2 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Product and Service

    • 14.6 Sanofi

      • 14.6.1 Sanofi Company Details

      • 14.6.2 Sanofi Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sanofi Type 1 Diabetes (T1D) Product and Service

    • 14.7 Samsung Bioepis

      • 14.7.1 Samsung Bioepis Company Details

      • 14.7.2 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Samsung Bioepis Type 1 Diabetes (T1D) Product and Service

    • 14.8 Janssen

      • 14.8.1 Janssen Company Details

      • 14.8.2 Janssen Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Janssen Type 1 Diabetes (T1D) Product and Service

    • 14.9 Bristol-Myers Squibb

      • 14.9.1 Bristol-Myers Squibb Company Details

      • 14.9.2 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product and Service

    • 14.10 Novo Nordisk

      • 14.10.1 Novo Nordisk Company Details

      • 14.10.2 Novo Nordisk Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novo Nordisk Type 1 Diabetes (T1D) Product and Service

    • 14.11 Merck

      • 14.11.1 Merck Company Details

      • 14.11.2 Merck Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Merck Type 1 Diabetes (T1D) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Type 1 Diabetes (T1D)

    • Figure Type 1 Diabetes (T1D) Picture

    • Table Global Type 1 Diabetes (T1D) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Type 1 Diabetes (T1D) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Type 1 Diabetes (T1D) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Type 1 Diabetes (T1D) Consumption by Country (2017-2022)

    • Figure United States Type 1 Diabetes (T1D) Consumption and Growth Rate (2017-2022)

    • Table Europe Type 1 Diabetes (T1D) Consumption and Growth Rate (2017-2022)

    • Figure China Type 1 Diabetes (T1D) Consumption and Growth Rate (2017-2022)

    • Figure Japan Type 1 Diabetes (T1D) Consumption and Growth Rate (2017-2022)

    • Figure India Type 1 Diabetes (T1D) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Type 1 Diabetes (T1D) Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Diabetes (T1D) Consumption Forecast by Country (2022-2028)

    • Figure United States Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Type 1 Diabetes (T1D) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rapid Acting Insulin Analogs Consumption and Growth Rate (2017-2022)

    • Figure Global Long Acting Insulin Analogs Consumption and Growth Rate (2017-2022)

    • Figure Global Premix Insulin Analogs Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid Acting Insulin Analogs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Long Acting Insulin Analogs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Premix Insulin Analogs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Type 1 Diabetes (T1D) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Type 1 Diabetes (T1D) Export by Region (Top 5 Countries) (2017-2028)

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Type 1 Diabetes (T1D) Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Type 1 Diabetes (T1D) Product and Service

    • Table Lexicon (Foundation Year, Company Profile and etc.)

    • Table Lexicon Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lexicon Type 1 Diabetes (T1D) Product and Service

    • Table Astellas (Foundation Year, Company Profile and etc.)

    • Table Astellas Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Type 1 Diabetes (T1D) Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Type 1 Diabetes (T1D) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Type 1 Diabetes (T1D) Product and Service

    • Table Samsung Bioepis (Foundation Year, Company Profile and etc.)

    • Table Samsung Bioepis Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samsung Bioepis Type 1 Diabetes (T1D) Product and Service

    • Table Janssen (Foundation Year, Company Profile and etc.)

    • Table Janssen Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Type 1 Diabetes (T1D) Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Type 1 Diabetes (T1D) Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Type 1 Diabetes (T1D) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Type 1 Diabetes (T1D) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Type 1 Diabetes (T1D) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US